|
1
|
Alberg AJ, Brock MV, Ford JG, Samet JM and
Spivack SD: Epidemiology of lung cancer: Diagnosis and management
of lung cancer, 3rd ed: American College of Chest Physicians
evidence-based clinical practice guidelines. Chest. 143 5
Suppl:e1S–e29S. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ettinger DS, Akerley W, Borghaei H, Chang
AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK,
Govindan R, et al: Non-small cell lung cancer. J Natl Compr Canc
Netw. 10:1236–1271. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Raponi M, Dossey L, Jatkoe T, Wu X, Chen
G, Fan H and Beer DG: MicroRNA classifiers for predicting prognosis
of squamous cell lung cancer. Cancer Res. 69:5776–5783. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kenfield SA, Wei EK, Stampfer MJ, Rosner
BA and Colditz GA: Comparison of aspects of smoking among the four
histological types of lung cancer. Tob Control. 17:198–204. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Antal CE, Hudson AM, Kang E, Zanca C,
Wirth C, Stephenson NL, Trotter EW, Gallegos LL, Miller CJ, Furnari
FB, et al: Cancer-associated protein kinase C mutations reveal
kinase's role as tumor suppressor. Cell. 160:489–502. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cancer Genome Atlas Research Network:
Comprehensive genomic characterization of squamous cell lung
cancers. Nature. 489:519–525. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang G, Lu X and Yuan L: LncRNA: A link
between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang J, Zhu N and Chen X: A novel long
noncoding RNA LINC01133 is upregulated in lung squamous cell cancer
and predicts survival. Tumor Biol. 36:7465–7471. 2015. View Article : Google Scholar
|
|
9
|
Schmidt LH, Spieker T, Koschmieder S,
Humberg J, Jungen D, Bulk E, Hascher A, Wittmer D, Marra A,
Hillejan L, et al: The long noncoding MALAT-1 RNA indicates a poor
prognosis in non-small cell lung cancer and induces migration and
tumor growth. J Thorac Oncol Off Pub Int Assoc Study Lung Cancer.
6:1984–1992. 2011.
|
|
10
|
Weber DG, Johnen G, Casjens S, Bryk O,
Pesch B, Jöckel KH, Kollmeier J and Brüning T: Evaluation of long
noncoding RNA MALAT1 as a candidate blood-based biomarker for the
diagnosis of non-small cell lung cancer. BMC Res Notes. 6:5182013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu XH, Liu ZL, Sun M, Liu J, Wang ZX and
Wei D: The long non-coding RNA HOTAIR indicates a poor prognosis
and promotes metastasis in non-small cell lung cancer. BMC Cancer.
13:4642013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakagawa T, Endo H, Yokoyama M, Abe J,
Tamai K, Tanaka N, Sato I, Takahashi S, Kondo T and Satoh K: Large
noncoding RNA HOTAIR enhances aggressive biological behavior and is
associated with short disease-free survival in human non-small cell
lung cancer. Biochem Biophys Res Commun. 436:319–324. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia
R, Liu YW, Liu XH, Zhang EB, Lu KH and Shu YQ: Long noncoding RNA
ANRIL promotes non-small cell lung cancer cell proliferation and
inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer
Ther. 14:268–277. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Naemura M, Murasaki C, Inoue Y, Okamoto H
and Kotake Y: Long noncoding RNA ANRIL regulates proliferation of
non-small cell lung cancer and cervical cancer cells. Anticancer
Res. 35:5377–5382. 2015.PubMed/NCBI
|
|
15
|
Nie FQ, Zhu Q, Xu TP, Zou YF, Xie M, Sun
M, Xia R and Lu KH: Long non-coding RNA MVIH indicates a poor
prognosis for non-small cell lung cancer and promotes cell
proliferation and invasion. Tumour Biol. 35:7587–7594. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wright JC, Mudge J, Weisser H, Barzine MP,
Gonzalez JM, Brazma A, Choudhary JS and Harrow J: Improving GENCODE
reference gene annotation using a high-stringency proteogenomics
workflow. Nat Commun. 7:117782016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
R Core Team: R: A language and environment
for statistical computingR Foundation for Statistical Computing.
Vienna: 2016
|
|
18
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Anders S and Huber W: Differential
expression of RNA-Seq data at the gene level-the DESeq package.
EMBL. 2013.
|
|
20
|
Zeng JH, Liang L, He RQ, Tang RX, Cai XY,
Chen JQ, Luo DZ and Chen G: Comprehensive investigation of a novel
differentially expressed lncRNA expression profile signature to
assess the survival of patients with colorectal adenocarcinoma.
Oncotarget. 8:16811–16828. 2017.PubMed/NCBI
|
|
21
|
Heagerty PJ, Thomas L and Pepe MS:
Time-dependent ROC curves for censored survival data and a
diagnostic marker. Biometrics. 56:337–344. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Porcher R: CORR Insights(®):
Kaplan-meier survival analysis overestimates the risk of revision
arthroplasty: A meta-analysis. Clin Orthopaed Relat Res.
473:3431–3442. 2015. View Article : Google Scholar
|
|
23
|
McHugh ML: The chi-square test of
independence. Biochem Med (Zagreb). 23:143–149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Adler P, Kolde R, Kull M, Tkachenko A,
Peterson H, Reimand J and Vilo J: Mining for coexpression across
hundreds of datasets using novel rank aggregation and visualization
methods. Genome Biol. 10:R1392009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C
and Jensen LJ: STRING v9. 1: Protein-protein interaction networks,
with increased coverage and integration. Nucleic Acids Res.
41:(Database Issue). D808–D815. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Saito R, Smoot ME, Ono K, Ruscheinski J,
Wang PL, Lotia S, Pico AR, Bader GD and Ideker T: A travel guide to
Cytoscape plugins. Nat Methods. 9:1069–1076. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
The Gene Ontology Consortium: Gene
ontology consortium: Going forward. Nucleic Acids Res.
43:D1049–D1056. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kanehisa M, Sato Y, Kawashima M, Furumichi
M and Tanabe M: KEGG as a reference resource for gene and protein
annotation. Nucleic Acids Res. 44:D457–D462. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang C, Guo H, Li B, Sui C, Zhang Y, Xia
X, Qin Y, Ye L, Xie F, Wang H, et al: Effects of Slit3 silencing on
the invasive ability of lung carcinoma A549 cells. Oncol Rep.
34:952–960. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kong R, Yi F, Wen P, Liu J, Chen X, Ren J,
Li X, Shang Y, Nie Y, Wu K, et al: Myo9b is a key player in
SLIT/ROBO-mediated lung tumor suppression. J Clin Invest.
125:4407–4420. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gocheva V, Naba A, Bhutkar A, Guardia T,
Miller KM, Li CM, Dayton TL, Sanchez-Rivera FJ, Kim-Kiselak C,
Jailkhani N, et al: Quantitative proteomics identify Tenascin-C as
a promoter of lung cancer progression and contributor to a
signature prognostic of patient survival. Proc Natl Acad Sci USA.
114:pp. E5625–E5634. 2017; View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tang YA, Chen CH, Sun HS, Cheng CP, Tseng
VS, Hsu HS, Su WC, Lai WW and Wang YC: Global Oct4 target gene
analysis reveals novel downstream PTEN and TNC genes required for
drug-resistance and metastasis in lung cancer. Nucleic Acids Res.
43:1593–1608. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gebauer F, Gelis S, Zander H, Meyer KF,
Wolters-Eisfeld G, Izbicki JR, Bockhorn M and Tachezy M: Tenascin-C
serum levels and its prognostic power in non-small cell lung
cancer. Oncotarget. 7:20945–20952. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Onion D, Isherwood M, Shridhar N, Mikalena
X, Madeleine LC, Laura JD, Maria A GM, Robert GP, Alex MRS, John
HS, et al: Multicomponent analysis of the tumour microenvironment
reveals low CD8 T cell number, low stromal caveolin-1 and high
tenascin-C and their combination as significant prognostic markers
in non-small cell lung cancer. Oncotarget. 9:1760–1771.
2017.PubMed/NCBI
|
|
36
|
Potiron VA, Roche J and Drabkin HA:
Semaphorins and their receptors in lung cancer. Cancer Lett.
273:1–14. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu TP, Mong-Hsun T, Jang-Ming L, Hsu CP,
Chen PC, Lin CW, Shih JY, Yang PC, Hsiao CK, Lai LC and Chuang EY:
Identification of a novel biomarker, SEMA5A, for non-small cell
lung carcinoma in nonsmoking women. Cancer Epidemiol Biomark
Prevent. 19:2590–2597. 2010. View Article : Google Scholar
|
|
38
|
Kelwick R, Desanlis I, Wheeler GN and
Edwards DR: The ADAMTS (A disintegrin and metalloproteinase with
thrombospondin motifs) family. Genome Biol. 16:1132015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hirohata S, Wang LW, Miyagi M, Yan L,
Seldin MF, Keene DR, Crabb JW and Apte SS: Punctin, a novel
ADAMTS-like molecule, ADAMTSL-1, in extracellular matrix. J Biol
Chem. 277:12182–12189. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Peng DH, Ungewiss C, Tong P, Byers LA,
Wang J, Canales JR, Villalobos PA, Uraoka N, Mino B, Behrens C, et
al: ZEB1 induces LOXL2-mediated collagen stabilization and
deposition in the extracellular matrix to drive lung cancer
invasion and metastasis. Oncogene. 36:1925–1938. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sun Y, Huang J and Yang Z: The roles of
ADAMTS in angiogenesis and cancer. Tumour Biol. 36:pp4039–4051.
2015. View Article : Google Scholar
|
|
42
|
Wang Y, Chen T, Huang H, Jiang Y, Yang L,
Lin Z, He H, Liu T, Wu B, Chen J, et al: miR-363-3p inhibits tumor
growth by targeting PCNA in lung adenocarcinoma. Oncotarget.
8:20133–20144. 2017.PubMed/NCBI
|
|
43
|
Gu L, Hickey RJ, Reckamp KL and Malkas LH:
Structural analysis identifies an orally active PCNA inhibitor that
inhibits the growth of small cell lung cancer cells without causing
significant toxicity to nonmalignant cells. J Thorac Oncol. 11
Suppl:S22–S23. 2016. View Article : Google Scholar
|
|
44
|
Yang J, Chen J, He J, Li J, Shi J, Cho WC
and Liu X: Wnt signaling as potential therapeutic target in lung
cancer. Expert Opin Ther Targets. 20:999–1015. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Stewart DJ: Wnt signaling pathway in
non-small cell lung cancer. J Natl Cancer Inst. 106:djt3562014.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Huang C, Ma R, Xu Y, Li N, Li Z, Yue J, Li
H, Guo Y and Qi D: Wnt2 promotes non-small cell lung cancer
progression by activating WNT/β-catenin pathway. Am J Cancer Res.
5:1032–1046. 2015.PubMed/NCBI
|
